Organon & Co. (OGN) financials: revenue, earnings and cash flow
Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Organon &’s revenue went from $7.8B in fiscal 2019 to $6.2B in fiscal 2025, a decline of about 3.7% a year.
Net income in fiscal 2025 was $187M, a net margin of 3.0%; the best year in this period was 2019 with $3.2B.
Over the twelve months to September 30, 2026, revenue was $6.1B and net income $213M.
Free cash flow was $538M in fiscal 2025 and positive in 7 of the 7 years shown.
The diluted share count rose 3% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $6.2B | $6.4B | $6.3B | $6.2B | $6.3B | $6.5B | $7.8B |
| Gross profit | $3.2B | $3.3B | $3.7B | $3.7B | $3.9B | $3.9B | $4.4B | $5.5B |
| Operating income | $949M | $929M | $1.3B | $1.2B | $1.5B | $1.8B | $2.8B | $3.7B |
| Net income | $213M | $187M | $864M | $1.0B | $917M | $1.4B | $2.2B | $3.2B |
| EPS (diluted) | $0.77 | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 | $8.52 | $12.69 |
| R&D | $357M | $366M | $469M | $528M | $471M | $443M | $210M | $220M |
| Revenue growth | — | −2.9% | +2.2% | +1.4% | −2.1% | −3.5% | −16.0% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $843M | $700M | $939M | $799M | $858M | $2.2B | $2.3B | $3.0B |
| Capital spending | -$168M | -$162M | -$175M | -$251M | -$196M | -$192M | -$255M | -$92M |
| Free cash flow | $675M | $538M | $764M | $548M | $662M | $2.0B | $2.0B | $2.9B |
| Dividends paid | $20M | $88M | $297M | $294M | $290M | $145M | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — |
| Stock-based pay | $72M | $77M | $105M | $101M | $75M | $59M | $40M | $41M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash | — | $574M | $675M | $693M | $706M | $737M | $12M | — |
| Debt | — | $8.8B | $9.0B | $8.9B | $9.1B | $9.4B | $31M | — |
| Equity | — | $752M | $472M | -$70M | -$892M | -$1.5B | $5.5B | $7.0B |
| Total assets | — | $12.9B | $13.1B | $12.1B | $11.0B | $10.7B | $10.1B | — |
| Shares (diluted) | 272M | 261M | 259M | 256M | 255M | 254M | 254M | 254M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 53.1% | 53.3% | 58.0% | 59.8% | 62.8% | 62.2% | 67.6% | 70.8% |
| Operating margin | 15.6% | 14.9% | 20.7% | 19.2% | 25.0% | 28.3% | 42.1% | 47.5% |
| Net margin | 3.5% | 3.0% | 13.5% | 16.3% | 14.8% | 21.4% | 33.1% | 41.4% |
| FCF margin | 11.1% | 8.7% | 11.9% | 8.8% | 10.7% | 31.2% | 31.1% | 37.6% |
| ROIC | — | 7.7% | 11.0% | 10.7% | 15.3% | 20.1% | 40.9% | 47.0% |
| ROE | — | 24.9% | 183.1% | -1461.4% | -102.8% | -89.6% | 39.4% | 45.7% |
Frequently asked questions
What is Organon &’s annual revenue?
$6.2B in fiscal 2025 and $6.1B over the twelve months to September 30, 2026.
How much profit does Organon & make?
Net income was $187M in fiscal 2025 (net margin 3.0%).
Is Organon &’s revenue growing?
No: revenue fell 2.9% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.